[Effects of the administration of norandrostenolone phenylpropionate on growth cartilage in human achondroplasia].
D000130:Achondroplasia / Q000188:drug therapy*; D000293:Adolescent; D000365:Age Determination by Skeleton; D001706:Biopsy; D002356:Cartilage / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D002648:Child; D002675:Child, Preschool; D003094:Collagen / Q000378:metabolism; D006023:Glycoproteins / Q000378:metabolism; D006025:Glycosaminoglycans / Q000378:metabolism; D006801:Humans; D007223:Infant; D009277:Nandrolone / Q000009:adverse effects / Q000627:therapeutic use*; D012313:RNA / Q000032:analysis; D013194:Staining and Labeling
D006023:Glycoproteins; D006025:Glycosaminoglycans; D012313:RNA; D009277:Nandrolone; D003094:Collagen
Effets de l'administration de norandrosténolone phényl-propionate sur le cartilage de croissance dans l'achondroplasie humaine.